Risk factors for erlotinib-induced hepatotoxicity: a retrospective follow-up study. [electronic resource]
Producer: 20190121Description: 988 p. digitalISSN:- 1471-2407
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- adverse effects
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cytochrome P-450 CYP3A Inducers -- therapeutic use
- Erlotinib Hydrochloride -- adverse effects
- Female
- Humans
- Liver -- drug effects
- Liver Neoplasms -- secondary
- Male
- Middle Aged
- Pancreatic Neoplasms -- drug therapy
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.